目的 对石杉碱甲注射液的杂质Ⅰ进行结构分析。方法 采用高效液相-飞行时间质谱联用(HPLC-Q-TOF)技术对杂质进行解析推断,利用制备型高效液相从石杉碱甲注射液中分离制备杂质Ⅰ,结合NMR技术进行结构确证。结果 利用质谱和核磁方法鉴定了石杉碱甲注射液中杂质Ⅰ:(11E)-7,8-二氯-5-氨基-11-亚乙基-5,8,9,10-四氢-7-甲基-5,9-亚甲基环辛三烯并吡啶-2(1H)-酮。结论 杂质Ⅰ为金属离子诱导降解产生,为石杉碱甲注射液质量控制和工艺优化提供参考依据。
Abstract
OBJECTIVE To identify the structure of an impurity of huperzine A injection.METHODS HPLC-QTOF-MS was adopted to analyze the structure of the impurity, which was further isolated and prepared by prep-HPLC and the structure was established on the basis of spectroscopic data.RESULTS The impurity was elucidated as(11E)-7,8-dichloro-5-amino-11-ethylidene-7-methyl-5,8,9,10-tetrahydro-5,9-methenecyclooctatriene pyridin-2(1H)-one.CONCLUSION The impurity was deduced as a metal ion-induced degradation product. This investigation provides reference for the improvement of quality control and process optimization of huperzine A injection.
关键词
石杉碱甲注射液 /
杂质Ⅰ /
液质联用 /
制备高效液相色谱法 /
核磁共振
{{custom_keyword}} /
Key words
huperzine A injection /
impurity Ⅰ /
HPLC-MS /
prep-HPLC /
NMR
{{custom_keyword}} /
中图分类号:
R927
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] XU H B,WANG X P,LIU G L. Pharmacological studies and clinical application of huperzine A . World Clin Drugs(世界临床药物),2014,35(1):60-63. [2] WANG X J,ZHANG H Y. Progress in clinical studies of huperzine A on improvement of cognitive function . Chin J New Drugs Clin Rem(中国新药与临床杂志),2012,31(12):707-712. [3] RAO Y K,WANG M,DING L,et al. Identification of the related substances in docetaxel injection by LC-MS/MS . Acta Pharm Sin (药学学报),2012,47(6):779-784. [4] RHONE K A,TANYA R,RANJALA R,et al. Chlorinated englerins with selective inhibition of renal cancer cell growth . J Nat Products,2012,75(3):459-463. [5] IRMA E S M,ALEJANDRA P D,PAUL R J,et al. Antibiotic terpenoid chlorodihydroquinones from a new marine actinomycete . J Natur Prod,2005,68(6):904-910. [6] ZHENG G G,LI H L. Determination the dissolution of huperzine A capsules by HPLC . Her Med(医药导报),2009,28(10):1351-1353. [7] ZHENG G G, LI H L. Study on dissolution method of huperzine A tablets . Drug Stand China(中国药品标准),2010,11(4):251-253. [8] Ch. P(2010) Vol Ⅱ(中国药典2010年版二部附录 ⅪⅩF) . 2010:204-206。
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}